Company: DERM
Filing Date: 2025-08-28
Form Type: 424B3
Source: 0001104659-25-084876
Chunk: 41

Company: Journey Medical Corp
Filing Date: 2025-08-28
Form: 424B3
Chunk 41
---
 secured or unsecured debt.

<div align='center'>13

DESCRIPTION OF WARRANTS</div>

General

We may issue warrants to purchase shares of our
common stock, preferred stock and/or debt securities. We may offer warrants separately or together with one or more additional warrants,
debt securities, shares of common stock, or shares of preferred stock, or any combination of those securities in the form of units, as
described in the applicable prospectus supplement. Each series of warrants will be issued under a separate warrant agreement to be entered
into between us and a bank or trust company, as warrant agent. The warrant agent will act solely as our agent in connection with the certificates
relating to the series of warrants and will not assume any obligation or relationship of agency or trust for or with any holders of warrants
certificates or beneficial owners of warrants. The following description sets forth certain general terms and provisions of the warrants
to which any prospectus supplement may relate. The particular terms of the warrant to which any prospectus supplement may relate and the
extent, if any, to which the general provisions may apply to the warrants so offered will be described in the applicable prospectus supplement.
To the extent that any particular terms of the warrant, warrant agreement or warrant certificates described in a prospectus supplement
differ from any of the terms described below, then the terms described below will be deemed to have been superseded by that prospectus
supplement. We encourage you to read the applicable warrant agreement and warrant certificate for additional information before you decide
whether to purchase any of our warrants.

We will provide in a prospectus supplement the
following terms of the warrants being issued:

| · | the specific designation and aggregate number of, and the price at which we will issue, the warrants; |

| · | the currency or currency units in which the offering price, if any, and the exercise price are payable; |

| · | the designation, amount and terms of the securities purchasable upon exercise of the warrants; |

| · | if applicable, the exercise price for shares of our common stock and the number of shares of common stock 
 to be received upon exercise of the warrants;                                                             |

| · | if applicable, the exercise price for shares of our preferred stock, the number of shares of preferred 
 stock to be received upon exercise, and a description of that series of our preferred stock;           |

| · | if applicable, the exercise price for our debt securities, the amount of debt securities to be received